PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer

References

• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855. doi:10.1136/gutjnl-2013-306627.
   PubMed Web of Science ®Google Scholar
• Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61. doi:10.1016/bs.acr.2020.10.001.
   Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet (London, England). 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2.
   PubMed Web of Science ®Google Scholar
• Zhang N, Osborn M, Gitsham P, Yen K, Miller JR, Oliver SG. Using yeast to place human genes in functional categories. Gene. 2003;303:121–129. doi:10.1016/S0378-1119(02)01142-3.
   PubMed Web of Science ®Google Scholar
• Küry S, Besnard T, Ebstein F, Khan TN, Gambin T, Douglas J, Bacino CA, Craigen WJ, Sanders SJ, Lehmann A, et al. De novo disruption of the proteasome regulatory subunit PSMD12 causes a syndromic neurodevelopmental disorder. Am J Hum Genet. 2017;100(2):352–363. doi:10.1016/j.ajhg.2017.01.003.
   PubMed Web of Science ®Google Scholar
• Wang T, Jiang X, Chen G, Xu J. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiol Aging. 2015;36(1):527–535. doi:10.1016/j.neurobiolaging.2014.07.044.
   PubMed Web of Science ®Google Scholar
• Kohrt SE, Awadallah WN, Phillips RA 3rd, Case TC, Jin R, Nanda JS, Yu X, Clark PE, Yi Y, Matusik RJ, et al. Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro. Mol Cancer Ther. 2021;20(2):398–409. doi:10.1158/1535-7163.MCT-20-0244.
   PubMed Web of Science ®Google Scholar
• Du X, Shen X, Dai L, Bi F, Zhang H, Lu C. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes. Biochem Biophys Res Commun. 2020;526(2):368–374. doi:10.1016/j.bbrc.2020.03.095.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Z, Xu H Liao, Y, Sun, C, Chen, Y, Sheng, M, Lan, Q, Wang, Z, et al. PSMD12 promotes glioma progression by upregulating the expression of Nrf2. Ann Transl Med. 2021;9(8):700. doi:10.21037/atm-21-1481.
   PubMed Web of Science ®Google Scholar
• Liu M, Nadar VC, Kozielski F, Kozlowska M, Yu W, Baas PW. Kinesin-12, a mitotic microtubule-associated motor protein, impacts axonal growth, navigation, and branching. J Neurosci Official J Neurosci Res. 2010;30(44):14896–14906. doi:10.1523/JNEUROSCI.3739-10.2010.
   PubMed Web of Science ®Google Scholar
• Eskova A, Knapp B, Matelska D, Reusing S, Arjonen A, Lisauskas T, Pepperkok R, Russell R, Eils R, Ivaska J, et al. An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrin. J Cell Sci. 2014;127(Pt 11):2433–2447. doi:10.1242/jcs.137281.
   PubMed Web of Science ®Google Scholar
• Wang J, Guo X, Xie C, Jiang J. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway. Br J Cancer. 2017;117(2):245–255. doi:10.1038/bjc.2017.165.
   PubMed Web of Science ®Google Scholar
• Li Q, Qiu J, Yang H, Sun G, Hu Y, Zhu D, Deng Z, Wang X, Tang J, Jiang R, et al. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. Cancer Lett. 2020;482:112–125. doi:10.1016/j.canlet.2019.11.008.
   PubMed Web of Science ®Google Scholar
• Zou JX, Duan Z, Wang J Sokolov A, Xu J, Chen CZ, Li JJ, Chen HW, et al. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance. Mol Cancer Res MCR. 2014;12(4):539–549. doi:10.1158/1541-7786.MCR-13-0459.
   PubMed Web of Science ®Google Scholar
• Zhao H, Bo Q, Wu Z, Liu Q, Li Y, Zhang N, Guo H, Shi B. <p>KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway. Cancer Manag Res. 2019;11:1857–1868. doi:10.2147/CMAR.S191681.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhan S, Lu H, Wang R, Xu Y, Zhang G, Cao L, Shi T, Zhang X, Chen W, et al. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death Dis. 2020;11(10):824. doi:10.1038/s41419-020-03041-4.
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. doi:10.1038/nrdp.2016.18.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK, et al. Diagnosis, staging, and management of hepatocellular Carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology (Baltimore, Md). 2018;68(2):723–750. doi:10.1002/hep.29913.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology (Baltimore, Md). 2003;37(2):429–442. doi:10.1053/jhep.2003.50047.
   PubMed Web of Science ®Google Scholar
• Khalil R, Kenny C, Hill RS, Mochida GH, Nasir R, Partlow JN, Barry BJ, Al-Saffar M, Egan C, Stevens CR, et al. PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features. Am J Med Genet Part B, Neuropsychiatr Genet Official Publ Int Soc Psychiatr Genet. 2018;177(8):736–745. doi:10.1002/ajmg.b.32688.
   PubMed Web of Science ®Google Scholar
• Montagut C, Settleman J. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 2009;283(2):125–134. doi:10.1016/j.canlet.2009.01.022.
   PubMed Web of Science ®Google Scholar
• Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W. Raf family kinases: old dogs have learned new tricks. Genes Cancer. 2011;2(3):232–260. doi:10.1177/1947601911407323.
   PubMedGoogle Scholar
• Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26(22):3279–3290. doi:10.1038/sj.onc.1210421.
   PubMed Web of Science ®Google Scholar
• Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176–188. doi:10.1016/j.semcancer.2019.12.007.
   PubMed Web of Science ®Google Scholar
• Simone V, Brunetti O, Lupo L, Testini M, Maiorano E, Simone M, Longo V, Rolfo C, Peeters M, Scarpa A, et al. Targeting angiogenesis in biliary tract cancers: an open option. Int J Mol Sci. 2017;18(2):418. doi:10.3390/ijms18020418.
   PubMed Web of Science ®Google Scholar
• Almeida AC, Maiato H. Chromokinesins. Current Biol: CB. 2018;28(19):R1131–r1135. doi:10.1016/j.cub.2018.07.017.
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu D, Zhao H, Cheng W, Xu F. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12). Aging. 2020;12(10):8858–8879. doi:10.18632/aging.103005.
   PubMedGoogle Scholar
• Gao X, Zhu L, Lu X, Wang Y, Li R, Jiang G. KIF15 contributes to cell proliferation and migration in breast cancer. Hum Cell. 2020;33(4):1218–1228. doi:10.1007/s13577-020-00392-0.
   PubMed Web of Science ®Google Scholar
• Ding L, Li B, Yu X, Li Z, Li X, Dang S, Lv Q, Wei J, Sun H, Chen H, et al. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis. Cancer Cell Int. 2020;20(1):125. doi:10.1186/s12935-020-01199-7.
   PubMed Web of Science ®Google Scholar
• Zeng H, Li T, Zhai D, Bi J, Kuang X, Lu S, Shan Z, Lin Y. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int J Biol Sci. 2020;16(12):2084–2093. doi:10.7150/ijbs.44204.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang W, Zhang J, Liu J, Sun F, Liu H, Hu J, Wang X, Wang X, Su P, et al. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer. Cancer Res. 2021;81(4):1026–1039. doi:10.1158/0008-5472.CAN-20-1965.
   PubMed Web of Science ®Google Scholar